Assessment of outcomes of hepatitis C treatment--reply
JAMA
.
2014 Dec 17;312(23):2571.
doi: 10.1001/jama.2014.14905.
Authors
Anita Kohli
1
,
Shyam Kottilil
2
Affiliations
1
Department of Critical Care Medicine, National Institutes of Health, Bethesda, Maryland.
2
Institute of Human Virology, University of Maryland School of Medicine, Baltimore.
PMID:
25514309
DOI:
10.1001/jama.2014.14905
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use*
Hepacivirus / physiology*
Hepatitis C, Chronic / drug therapy*
Humans
Substances
Antiviral Agents